Source - SMW
Numis today reaffirms its buy investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and set its price target at 150p.

Related Charts

Circassia Pharmaceuticals (CIR)

-0.50p (-0.55%)
delayed 09:43AM